noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

City of Marion, IA

City Offices to Close in Observance of Upcoming Holidays
University of Hawai?i at Manoa

Football-field-sized balloon takes flight over Antarctica in quest for[...]
Elizabeth Warren

Warren, Casar Warn DOJ, FCC of Potential Competition, Cost Issues[...]

Healthcare

Cassava Sciences Inc.

12/17/2025 | Press release | Distributed by Public on 12/17/2025 15:12

Management Change/Compensation (Form 8-K)

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 12, 2025, the Board of Directors (the "Board") of Cassava Sciences, Inc. (the "Company") approved cash bonus awards for calendar 2025 for the Company's named executive officers in recognition of their contributions to the Company as follows:

Name	Title	Bonus Amount
Richard J. Barry	President & Chief Executive Officer	$ 355,000
Eric J. Schoen	Chief Financial Officer	$ 215,000

For 2025, the Board established performance measures and goals which were designed to be challenging yet achievable with strong management performance, focused primarily on (1) exploring the use of simufilam in Tuberous Sclerosis Complex (TSC)-related epilepsy, (2) building a team with appropriate expertise in TSC-related epilepsy, and (3) budgeting and expense management.

Cassava Sciences Inc. published this content on December 17, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 17, 2025 at 21:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]